Publications

Editorial Ppublish

PubMed: 35382154 DOI: 10.1016/j.crphar.2022.100099

COVID-19 therapy, from lung disease to systemic disorder.

Curr Res Pharmacol Drug Discov 3:100099

Authors: Simon Pitchford, Isabella Zanella

Affiliations

  • King's College London, London, United Kingdom.
  • University of Brescia, Department of Molecular and Translational Medicine, Brescia, Italy.
  • Clinical Chemistry Laboratory, Cytogenetics and Molecular Genetics Section, Diagnostic Department, ASST Spedali Civili Di Brescia, Brescia, Italy.

MeSH

Therapeutics, Lung Diseases, Covid-19